Healthcare provider profile · identity verified

Gary L. Howard, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · CALERA, AL · NPI 1194714428

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Gary L. Howard, M.D. received $134.96 in general payments during 2025 across 7 reported records.

AstraZeneca Pharmaceuticals LP accounted for 29.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 7 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Ozempic, Rybelsus.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 169 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Symbicort by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 430 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rybelsus by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$134.96

7 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$40.30	29.9%	2	2025
Abbott Laboratories	Unresolved — no canonical attribution shown	$37.46	27.8%	2	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$24.76	18.4%	1	2025
Antares Pharma, Inc.	Unresolved — no canonical attribution shown	$18.33	13.6%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$14.11	10.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$134.96	7

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FARXIGA Normalized: farxiga	Drug	AstraZeneca Pharmaceuticals LP	$40.30	2	2025
Source payment records 2025-06-04 · AstraZeneca Pharmaceuticals LP · $23.61 · Open Payments source 2025-10-14 · AstraZeneca Pharmaceuticals LP · $16.69 · Open Payments source
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$37.46	2	2025
Source payment records 2025-09-17 · Abbott Laboratories · $18.73 · Open Payments source 2025-10-31 · Abbott Laboratories · $18.73 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$24.76	1	2025
Source payment records 2025-03-20 · Novo Nordisk Inc · $24.76 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$24.76	1	2025
Source payment records 2025-03-20 · Novo Nordisk Inc · $24.76 · Open Payments source
XYOSTED Normalized: xyosted	Drug	Antares Pharma, Inc.	$18.33	1	2025
Source payment records 2025-06-02 · Antares Pharma, Inc. · $18.33 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$14.11	1	2025
Source payment records 2025-05-20 · Amgen Inc. · $14.11 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$14.11	1	2025
Source payment records 2025-05-20 · Amgen Inc. · $14.11 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
FARXIGA farxiga	2025	Farxiga	2024	169	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	430	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	14 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	169	42
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	25	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	430	82
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	820	111
Gabapentin	Gabapentin	775	138
Tizanidine Hcl	Tizanidine Hcl	771	205
Levothyroxine Sodium	Levothyroxine Sodium	761	201
Pantoprazole Sodium	Pantoprazole Sodium	628	214
Atorvastatin Calcium	Atorvastatin Calcium	610	201
Metformin Hcl	Metformin Hcl	495	149
Rosuvastatin Calcium	Rosuvastatin Calcium	484	161
Ozempic	Semaglutide	430	82
Famotidine	Famotidine	371	133
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	363	45
Tamsulosin Hcl	Tamsulosin Hcl	322	108
Amlodipine Besylate	Amlodipine Besylate	308	102
Trazodone Hcl	Trazodone Hcl	308	98
Topiramate	Topiramate	292	97
Eliquis	Apixaban	289	57
Albuterol Sulfate Hfa	Albuterol Sulfate	285	120
Lisinopril	Lisinopril	275	79
Spironolactone	Spironolactone	274	99
Losartan Potassium	Losartan Potassium	272	92
Metoprolol Succinate	Metoprolol Succinate	269	92
Lamotrigine	Lamotrigine	260	82
Omeprazole	Omeprazole	247	75
Ondansetron Hcl	Ondansetron Hcl	245	74
Methylprednisolone	Methylprednisolone	233	163
Furosemide	Furosemide	226	85
Carvedilol	Carvedilol	211	65
Valsartan	Valsartan	207	63
Quetiapine Fumarate	Quetiapine Fumarate	205	51
Doxycycline Hyclate	Doxycycline Hyclate	203	142
Meloxicam	Meloxicam	193	70
Mounjaro	Tirzepatide	186	40
Sertraline Hcl	Sertraline Hcl	180	55
Fluticasone Propionate	Fluticasone Propionate	173	103
Diclofenac Sodium	Diclofenac Sodium	172	69
Farxiga	Dapagliflozin Propanediol	169	42
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	169	29
Metoprolol Tartrate	Metoprolol Tartrate	165	54
Potassium Chloride	Potassium Chloride	163	64
Doxepin Hcl	Doxepin Hcl	150	59
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	148	45
Prednisone	Prednisone	147	104
Montelukast Sodium	Montelukast Sodium	140	48
Amoxicillin	Amoxicillin	136	97
Simvastatin	Simvastatin	134	39
Glimepiride	Glimepiride	131	42
Pravastatin Sodium	Pravastatin Sodium	131	41
Propranolol Hcl	Propranolol Hcl	131	46
Linzess	Linaclotide	127	49
Myrbetriq	Mirabegron	117	28
Tramadol Hcl	Tramadol Hcl	116	28
Ropinirole Hcl	Ropinirole Hcl	114	37
Buspirone Hcl	Buspirone Hcl	113	41
Jardiance	Empagliflozin	112	27
Fluconazole	Fluconazole	111	66
Clopidogrel	Clopidogrel Bisulfate	107	36
Mirtazapine	Mirtazapine	107	38
Olanzapine	Olanzapine	107	39
Azithromycin	Azithromycin	103	82
Escitalopram Oxalate	Escitalopram Oxalate	103	33
Januvia	Sitagliptin Phosphate	102	22
Risedronate Sodium	Risedronate Sodium	100	44
Citalopram Hbr	Citalopram Hydrobromide	98	29
Minocycline Hcl	Minocycline Hcl	98	70
Triamcinolone Acetonide	Triamcinolone Acetonide	98	58
Imipramine Hcl	Imipramine Hcl	97	33
Pioglitazone Hcl	Pioglitazone Hcl	96	33
Cefuroxime	Cefuroxime Axetil	95	81
Esomeprazole Magnesium	Esomeprazole Magnesium	92	28
Rizatriptan	Rizatriptan Benzoate	92	36
Ciprofloxacin Hcl	Ciprofloxacin Hcl	91	72
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	31
Hydroxyzine Hcl	Hydroxyzine Hcl	85	34
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	85	26
Clonidine Hcl	Clonidine Hcl	84	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	84	28
Telmisartan	Telmisartan	84	27
Duloxetine Hcl	Duloxetine Hcl	82	27
Colchicine	Colchicine	80	27
Metoclopramide Hcl	Metoclopramide Hcl	80	54
Allopurinol	Allopurinol	79	23
Oxybutynin Chloride Er	Oxybutynin Chloride	79	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	27
Ezetimibe	Ezetimibe	77	29
Fluoxetine Hcl	Fluoxetine Hcl	76	22
Meclizine Hcl	Meclizine Hcl	76	36
Terbinafine Hcl	Terbinafine Hcl	76	34
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	75	47
Ondansetron Odt	Ondansetron	73	37
Hydrochlorothiazide	Hydrochlorothiazide	70	28
Nystatin	Nystatin	70	29
Alprazolam	Alprazolam	69	suppressed
Bupropion Hcl Sr	Bupropion Hcl	69	24
Metformin Hcl Er	Metformin Hcl	68	24
Trulicity	Dulaglutide	66	12
Celecoxib	Celecoxib	65	17
Estradiol	Estradiol	64	27
Synthroid	Levothyroxine Sodium	64	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	61	22
Carbamazepine	Carbamazepine	61	28
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	61	suppressed
Levofloxacin	Levofloxacin	61	54
Valacyclovir	Valacyclovir Hcl	60	29
Aripiprazole	Aripiprazole	59	24
Sumatriptan Succinate	Sumatriptan Succinate	59	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	58	21
Testosterone Cypionate	Testosterone Cypionate	55	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	21
Mometasone Furoate	Mometasone Furoate	52	26
Naltrexone Hcl	Naltrexone Hcl	52	19
Lovastatin	Lovastatin	50	16
Oxybutynin Chloride	Oxybutynin Chloride	50	23
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Mupirocin	Mupirocin	49	30
Chlorthalidone	Chlorthalidone	48	18
Testosterone	Testosterone	48	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	44
Atenolol	Atenolol	46	13
Colestipol Hcl	Colestipol Hcl	46	15
Pregabalin	Pregabalin	46	12
Bupropion Xl	Bupropion Hcl	45	14
Cephalexin	Cephalexin	45	25
Lidocaine	Lidocaine	45	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	16
Lithium Carbonate	Lithium Carbonate	43	15
Methylphenidate Hcl	Methylphenidate Hcl	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	42	13
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	41	13
Zonisamide	Zonisamide	41	19
Lansoprazole	Lansoprazole	40	14
Paroxetine Hcl	Paroxetine Hcl	40	15
Risperidone	Risperidone	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Zafirlukast	Zafirlukast	40	suppressed
Niacin Er	Niacin	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Clonazepam	Clonazepam	37	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	37	15
Hydralazine Hcl	Hydralazine Hcl	37	12
Irbesartan	Irbesartan	37	suppressed
Primidone	Primidone	37	12
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	36	13
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	36	15
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	35	12
Baclofen	Baclofen	35	suppressed
Dexamethasone	Dexamethasone	35	30
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Divalproex Sodium	Divalproex Sodium	35	suppressed
Donepezil Hcl	Donepezil Hcl	35	16
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Ibuprofen	Ibuprofen	34	17
Nabumetone	Nabumetone	34	17
Alendronate Sodium	Alendronate Sodium	33	suppressed
Divalproex Sodium Er	Divalproex Sodium	33	11
Naproxen	Naproxen	33	12
Lorazepam	Lorazepam	32	suppressed
Glipizide Er	Glipizide	31	11
Metronidazole	Metronidazole	31	23
Finasteride	Finasteride	30	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	27
Memantine Hcl	Memantine Hcl	29	13
Sucralfate	Sucralfate	29	12
Clindamycin Hcl	Clindamycin Hcl	28	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	28	12
Glipizide	Glipizide	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	26	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	26	suppressed
Torsemide	Torsemide	26	12
Levetiracetam	Levetiracetam	25	suppressed
Promethazine Hcl	Promethazine Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Varenicline Tartrate	Varenicline Tartrate	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	11
Letrozole	Letrozole	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Loperamide	Loperamide Hcl	23	18
Azelastine Hcl	Azelastine Hcl	22	12
Clobetasol Propionate	Clobetasol Propionate	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Gemtesa	Vibegron	22	11
Labetalol Hcl	Labetalol Hcl	22	suppressed
Methotrexate	Methotrexate Sodium	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Tresiba Flextouch U-200	Insulin Degludec	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Constulose	Lactulose	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Lactulose	Lactulose	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	19	13
Bupropion Hcl	Bupropion Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Metolazone	Metolazone	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Clarithromycin	Clarithromycin	15	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Rexulti	Brexpiprazole	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Digoxin	Digoxin	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	13
Nifedipine Er	Nifedipine	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ammonium Lactate	Ammonium Lactate	12	11
Caplyta	Lumateperone Tosylate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Nurtec Odt	Rimegepant Sulfate	12	suppressed
Ramipril	Ramipril	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$134.96 · 7 records	AstraZeneca Pharmaceuticals LP	FARXIGA, FREESTYLE LIBRE 3, OTEZLA, Ozempic, REPATHA, Rybelsus, XYOSTED	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Farxiga play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error